PELLEGRINI, FABIO
 Distribuzione geografica
Continente #
NA - Nord America 201
EU - Europa 33
AS - Asia 17
AF - Africa 2
SA - Sud America 2
Totale 255
Nazione #
US - Stati Uniti d'America 201
FR - Francia 14
VN - Vietnam 14
IT - Italia 8
DE - Germania 7
FI - Finlandia 3
CN - Cina 2
ZA - Sudafrica 2
BR - Brasile 1
ES - Italia 1
IN - India 1
PE - Perù 1
Totale 255
Città #
Ashburn 17
Fairfield 15
Dong Ket 14
Buffalo 12
Cambridge 7
Woodbridge 6
Chicago 5
Houston 5
Seattle 5
Wilmington 5
Nuremberg 4
San Diego 4
Bari 3
Helsinki 3
Las Vegas 3
Los Angeles 3
Boardman 2
Clearwater 2
Francavilla Fontana 2
Henderson 2
Provo 2
Shanghai 2
Taranto 2
Ann Arbor 1
Atlanta 1
Austin 1
Avilés 1
Bengaluru 1
Council Bluffs 1
Dallas 1
Frankfurt am Main 1
Jersey City 1
Kandel 1
Lima 1
Muizenberg 1
New Orleans 1
New York 1
Paris 1
Pittsburgh 1
Portland 1
Providence 1
Recife 1
Santa Clara 1
Silverton 1
Totale 146
Nome #
Comparative efficacy of switching to natalizumab in active multiple sclerosis, file dd9e0c68-08f9-1e9c-e053-3a05fe0a45ef 48
The Long-Term Impact of Renin-Angiotensin System (RAS) Inhibition on Cardiorenal Outcomes (LIRICO): A Randomized, Controlled Trial, file dd9e0c6a-c5e7-1e9c-e053-3a05fe0a45ef 47
Natalizumab treatment shows low cumulative probabilities of confirmed disability worsening to EDSS milestones in the long-term setting, file dd9e0c68-115b-1e9c-e053-3a05fe0a45ef 46
Comparative efficacy of first-line natalizumab vs IFN-β or glatiramer acetate in relapsing MS, file dd9e0c67-e10f-1e9c-e053-3a05fe0a45ef 45
Epoch analysis of on-treatment disability progression events over time in the Tysabri Observational Program (TOP), file dd9e0c6a-6225-1e9c-e053-3a05fe0a45ef 40
Greater sensitivity to multiple sclerosis disability worsening and progression events using a roving versus a fixed reference value in a prospective cohort study, file dd9e0c68-115f-1e9c-e053-3a05fe0a45ef 36
null, file dd9e0c63-7cd0-1e9c-e053-3a05fe0a45ef 1
Totale 263
Categoria #
all - tutte 1.056
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 1.056


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20202 0 0 0 0 0 0 0 0 0 0 2 0
2020/202171 0 0 0 0 1 10 6 6 9 10 10 19
2021/202290 6 0 3 2 14 3 3 4 6 3 31 15
2022/202374 2 5 33 14 3 2 2 1 0 0 12 0
2023/202426 0 0 1 0 7 2 9 6 1 0 0 0
Totale 263